This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
OTC
HealthdirectFree Australian health advice you can count on.
10MG/VIAL, Powder
INN: CARFILZOMIB
Data updated: 2026-04-25
Available in:
🇬🇧🇫🇷🇵🇹
Form
POWDER
Dosage
10MG/VIAL
Route
INTRAVENOUS
Storage
—
About This Product
Manufacturer
User Reviews
Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
ONYX PHARMACEUTICALS INC A WHOLLY OWNED SUB OF AMGEN INC
ATC Code
L01XG02
Source
FDA_OB · 202714
(
ARTG
)
Kyprolis is indicated for the treatment of patients with relapsed or refractory multiple myeloma who have received at least one prior therapy as part of combination therapy with: dexamethasone, or lenalidomide and dexamethasone, or daratumumab and dexamethasone, or isatuximab and dexamethasone
⚠️ Warnings
• Caution should be exercised in patients with history of heart arrest, congestive heart failure, high blood pressure, any allergy, who are taking other medications, during pregnancy and breastfeeding.
• It may cause fatigue, dizziness, fainting, and/or low blood pressure, do not drive a car or operate machinery while taking this medication.
• Patient may experience shortness of breath, if it is so consult with your healthcare provider.
